Search Results for 'amyris'

Amyris aims for huge second half for 2014 as in-line Q2 earnings announced

The Pharaohs of Farnesene continue to pick up momentum. In California, Amyris reported a net loss of $35.5M for the second quarter of 2014 on sales of $9.3M, with a 5.4 percent increase in sales over Q2 2013. Renewable product sales were $4.4M for the quarter, while “Recognized grants and collaborations revenues” reached $4.9M. In […]

August 10, 2014 More

Amyris partners with Gol on first international commercial flights

In Florida, Amyris has partnered with Brazilian airline GOL to begin the first commercial route with farnesane, the recently approved renewable jet fuel. GOL has committed to fly its Boeing 737 fleet with up to a 10 percent blend of the renewable fuel on its U.S. to Brazil routes starting with initial flights later this […]

July 9, 2014 More

Total, Amyris say their renewable jet fuel is ready to go

Renewable Jet Fuel Developed by Total & Amyris Meets Newly Updated ASTM Standard for Jet A/A1 The Digest received news from California that ASTM has revised the D7566, the Standard Specification for Aviation Turbine Fuel Containing Synthesized Hydrocarbons to include the use of renewable farnesane as a blending component in jet fuels for commercial aviation. […]

June 16, 2014 More

Amyris and Total to begin marketing drop-in jet fuel following ASTM revision

In California, with the newly revised ASTM standard for jet fuel, Amyris and Total begin to prepare to market a drop-in jet fuel that contains up to 10% blends of renewable farnesane. Developed by Total and Amyris, this new jet fuel blend meets the rigorous performance requirements set for Jet A/A-1 fuel used by the […]

June 16, 2014 More

Amyris prices $75m in Convertible Senior Notes due in 2019

In California, Amyris has priced $75 million of 6.5% Convertible Senior Notes that will be due in 2019. Amyris also granted the initial purchaser of the notes an option to purchase up to an additional $15 million aggregate principal amount of the notes. The sale is expected to close on May 29, 2014, subject to […]

May 25, 2014 More

Spring blossoms: Amyris swings to positive earnings for Q1 2014, affirms guidance

In California, Amyris announced net income of $16.4M on revenues of $6.2M for Q1 2014, after reporting a $32.6M loss in Q1 2013 on revenues of $9.0M. The change in net income was primary due to a non-cash benefit relating to outstanding convertible notes, a result of a decrease in the Company’s stock price at […]

May 11, 2014 More

Amyris gets RSB certification

In Brazil, Amyris has completed the Roundtable on Sustainable Biomaterials (RSB) certification process. RSB’s sustainability certification covers Amyris’s renewable hydrocarbon molecules, initially farnesene, produced from Brazilian sugarcane feedstock at the Amyris biorefinery in Brotas, São Paulo state. Farnesene is a liquid, long-chain, branched renewable hydrocarbon that serves as precursor in many applications ranging from specialty […]

May 7, 2014 More

Amyris strikes R&D deal with BASF

In California, Amyris announced that it is entering into a collaborative research and development agreement with BASF. Under the agreement, Amyris will use its strain engineering technology to develop a microorganism capable of producing a target molecule identified by BASF. Based on success of the initial development program, the companies expect to collaborate further on […]

April 3, 2014 More

Amyris extends deal with Kuraray for Biofene

In California, Amyris and Kuraray announced the expansion and extension of their ongoing collaboration in high performance polymers using Biofene®, Amyris’s brand of renewable farnesene. Under the transaction agreements, the parties have extended the duration of the research and development portion of their collaboration for at least two more years. The parties also reaffirmed their […]

April 1, 2014 More

X-Crobes: Kuraray invests in Amyris, what’s next for synth-bio and performance molecules?

There are microbes and X-Crobes. The former: what you find in nature. The latter: strange beings from the Digest Multiverse. Poly-performing platform organisms endowed by synthetic biology with Xtraordinary properties. The X-Crobes are back in the spotlight this week with news that Kuraray is investing in Amyris. Here’s what’s up, and why. In California, Amyris and […]

April 1, 2014 More